XFOR - X4 Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5159.23M
Enterprise Value 3138.47M
Trailing P/E N/A
Forward P/E 1-3.36
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.93
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-4.16

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 318.75%
S&P500 52-Week Change 31.52%
52 Week High 329.46
52 Week Low 36.90
50-Day Moving Average 312.95
200-Day Moving Average 316.24

Share Statistics

Avg Vol (3 month) 329.7k
Avg Vol (10 day) 311.57k
Shares Outstanding 514.29M
Float 9.99M
% Held by Insiders 15.18%
% Held by Institutions 130.03%
Shares Short (Jul 15, 2019) 4236.32k
Short Ratio (Jul 15, 2019) 44.36
Short % of Float (Jul 15, 2019) 42.19%
Short % of Shares Outstanding (Jul 15, 2019) 41.90%
Shares Short (prior month Jun 14, 2019) 4168.2k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 26/1
Last Split Date 3Mar 14, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -33.32M
Net Income Avi to Common (ttm)-39.66M
Diluted EPS (ttm)-5.90
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)22.3M
Total Cash Per Share (mrq)1.79
Total Debt (mrq)22.78M
Total Debt/Equity (mrq)77.37
Current Ratio (mrq)1.59
Book Value Per Share (mrq)4.38

Cash Flow Statement

Operating Cash Flow (ttm)-30.99M
Levered Free Cash Flow (ttm)N/A